CONMED
CNMD
249 hedge funds and large institutions have $3.46B invested in CONMED in 2020 Q4 according to their latest regulatory filings, with 41 funds opening new positions, 95 increasing their positions, 76 reducing their positions, and 30 closing their positions.
47% more capital invested
Capital invested by funds: $2.34B → $3.46B (+$1.11B)
37% more first-time investments, than exits
New positions opened: 41 | Existing positions closed: 30
25% more repeat investments, than reductions
Existing positions increased: 95 | Existing positions reduced: 76
4% more funds holding
Funds holding: 240 → 249 (+9)
1.71% more ownership
Funds ownership: 106.07% → 107.78% (+1.7%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
83% less call options, than puts
Call options by funds: $3.12M | Put options by funds: $18.2M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EARNEST Partners
Atlanta,
Georgia
|
+$43.5M |
| 2 |
Loomis, Sayles & Company
Boston,
Massachusetts
|
+$21.5M |
| 3 |
BlackRock
New York
|
+$20.5M |
| 4 |
EAM
Eagle Asset Management
St Petersburg,
Florida
|
+$18.4M |
| 5 |
PCM
Peregrine Capital Management
Minneapolis,
Minnesota
|
+$17.5M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
-$74.7M |
| 2 |
SCM
Scopia Capital Management
New York
|
-$31.9M |
| 3 |
Balyasny Asset Management
Chicago,
Illinois
|
-$10.9M |
| 4 |
RSCM
Rock Springs Capital Management
Baltimore,
Maryland
|
-$9.66M |
| 5 |
Principal Financial Group
Des Moines,
Iowa
|
-$9.43M |
CNMD Hedge Fund Activity: Q4 2020 in Review
249 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in CONMED (CNMD) for Q4 2020, worth a combined $3.46B — up 47% from $2.34B a quarter earlier.
Buyers outnumbered sellers: 41 funds opened new CNMD positions and 30 closed out — a net gain of 11 holders — while 95 added to existing stakes and 76 trimmed.
The largest buyer was EARNEST Partners, adding an estimated $43.5M. The largest seller was Point72 Asset Management, cutting an estimated $74.7M.
- 249 institutional investors held CONMED (CNMD) as of Q4 2020, up from 240 in Q3 2020.
- Funds reported $3.46B of CONMED stock for Q4 2020, up 47% quarter-over-quarter.
- 41 funds opened new CONMED positions in Q4 2020 and 30 closed out, a net change of +11 holders.
- The largest CONMED buyer in Q4 2020 was EARNEST Partners, an estimated $43.5M added.
- The largest CONMED seller in Q4 2020 was Point72 Asset Management, an estimated $74.7M sold.
Based on aggregated 13F filings for Q4 2020.